Adults using a GLP-1 had a similar risk for kidney cancer as those using an SGLT2 inhibitor
Both omeprazole and esomeprazole inhibit CYP2C19, leading to: Reduced formation of active clopidogrel metabolite Decreased antiplatelet efficacy Increased risk of thrombotic events (MI, stroke, stent thrombosis) Clinical takeaway: When gastric protection is required in patients on clopidogrel, consider safer alternatives such as: Pantoprazole Rabeprazole This simple switch can significantly improve therapeutic outcomes and patient safety
The improvement in insulin metabolism parameters is associated with L-carnitine potentially modulating the expression of glycolytic and gluconeogenic enzymes involved in mitochondrial glucose oxidation and facilitating the transport of free fatty acids or their action as acetyl group donors in high-energy metabolism situations
Rapid Heartbeat : A racing heart rate, often linked to a drop in blood sugar levels during the night
Trippe, J., Mix, A., Aydin-Abidin, S., Funke, K
